Investors

Webcast ImageWebcast - Live
OraSure Technologies, Inc. at the 2017 Cantor Fitzgerald Global Healthcare Conference
09/26/17 at 2:15 p.m. ET
OraSure Technologies, Inc. at the 2017 Cantor Fitzgerald Global Healthcare Conference
Tuesday, September 26, 2017 2:15 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
2016 Annual Report on Form 10-K - PDF 2016 Annual Report on Form 10-K
Fact Sheet - PDF Fact Sheet
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$21.74
Change (%) Stock is Up 0.13 (0.00%)
Volume436,293
Data as of 09/22/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
09/20/17OraSure Technologies to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
BETHLEHEM, Pa., Sept. 20, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 2017 Cantor Fitzgerald Global Healthcare Conference.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on September 26, 2017, at approximately 2:15 PM Eastern Time (11:15 A... 
Printer Friendly Version
09/06/17OraSure Technologies to Present at CL King’s 15th Annual Best Ideas Conference
BETHLEHEM, Pa., Sept. 06, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at CL King’s 15th Annual Best Ideas Conference.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on September 14th, 2017, at approximately 11:45 AM Eastern Time (8:45 AM Pacific ... 
Printer Friendly Version
08/02/17OraSure Announces 2017 Second Quarter Financial Results
BETHLEHEM, Pa., Aug. 02, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and six months ended June 30, 2017. Financial Highlights Consolidated net revenues for the second quarter of 2017 were $40.2 million, a 28% increase from the second quarter of 2016. Net product revenues were $39.1 million, representing a 42% increase over the... 
Printer Friendly Version
08/01/17OraSure Technologies to Present at the Canaccord Genuity 37th Annual Growth Conference
BETHLEHEM, Pa., Aug. 01, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Canaccord Genuity 37th Annual Growth Conference in Boston, Massachusetts.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on August 10, 2017, at approximately 8:00 AM Ea... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
09/26/17 2:15 p.m. ET
OraSure Technologies, Inc. at the 2017 Cantor Fitzgerald Global Healthcare Conference
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet